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Summary
Context: Adrenal incidentalomas (AI) represent an increasingly common problem in modern endocrine practice. The 
diagnostic approach to AIs can be challenging and occasionally reveals surprising features. Here we describe two rare 
cases of complex adrenal lesions consisting of phaeochromocytomas with synchronous metastases from extra-adrenal 
primaries.
Case descriptions: Patient 1 – a 65-year-old gentleman with a newly diagnosed malignant melanoma was found to 
harbour an adrenal lesion with suspicious radiographic characteristics. Percutaneous adrenal biopsy was consistent 
with adrenocortical adenoma. After excision of the skin melanoma and regional lymphatic metastases, he was followed 
up without imaging. Three years later, he presented with abdominal discomfort and enlargement of his adrenal 
lesion, associated with high plasma metanephrines. Adrenalectomy revealed a mixed tumour consisting of a large 
phaeochromocytoma with an embedded melanoma metastasis in its core. Patient 2 – a 63-year-old lady with a history of 
NF-1-relatedphaeochromocytoma20 yearsagoandpreviousbreastcancerpresentedwithanewadrenallesiononthe
contralateral side. Plasma normetanephrine was markedly elevated. Elective adrenalectomy revealed an adrenal tumour 
consistingofchromaffincellsintermixedwithbreastcarcinomacells.
Conclusions: Adrenal incidentalomas require careful evaluation to exclude metastatic disease, especially in the 
context of a history of previous malignancy. Adrenal biopsy provides limited and potentially misleading information. 
Phaeochromocytomas are highly vascularised tumours that may function as a sieve, extracting and retaining irregularly 
shaped cancer cells, thereby yielding adrenal masses with intriguing dual pathology.
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Learning points:
•• Adrenal incidentalomas require careful evaluation focused on exclusion of underlying hormone excess and 
malignant pathology.
•• Adrenal biopsy can be misleading and should only be considered in select cases.
•• Phaeochromocytomas harbouring intratumoural metastases from other, extra-adrenal primary malignancies 
represent rare pathological entities that highlight the complexities that can be presented by adrenal tumours.
Background
Adrenal incidentalomas (AI), that is, adrenal masses 
discovered incidentally during diagnostic imaging 
not prompted by known or suspected adrenal 
disease, represent an increasingly common diagnostic 
conundrum, due to the widespread use of cross-sectional 
imaging (1). Although the majority of AIs represent 
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benign adenomas, a substantial minority consist of 
malignant tumours, including adrenocortical carcinomas, 
phaeochromocytomas and adrenal metastases from other 
primary malignancies (1, 2). The approach to a new 
adrenal lesion should aim to exclude tumour-related 
hormone excess and the possibility of malignancy. Here 
we present two highly unusual cases characterised by dual 
pathology contained in one adrenal mass.
Case presentation
Case 1
A 65-year-old gentleman initially presented to the 
Dermatology clinic with a longstanding pedunculated 
skin lesion, which was diagnosed as nodular melanoma 
on excision biopsy. His past medical history included 
non-Hodgkin’s lymphoma, successfully treated with 
chemotherapy and radiotherapy 30 years ago (discharged 
from follow-up) and difficult-to-treat hypertension. He 
reported an extensive family history of malignancies, 
including two affected siblings (non-Hodgkin’s lymphoma) 
and his mother (lung cancer). ACT scan revealed an 
enlarged inguinal node and a 7 cm heterogeneous left 
adrenal mass, raising the suspicion of an adrenal melanoma 
metastasis. Fine-needle aspiration of the inguinal node 
was consistent with lymphatic melanoma metastasis. To 
complete the staging of his malignant disease, a CT-guided 
adrenal biopsy was arranged after biochemical exclusion 
of phaeochromocytoma with three negative 24-h urine 
catecholamine collections (adrenaline: 50, 44, 42 nmol 
(reference range (RR): <190 nmol); noradrenaline: 559, 
516, 496 nmol (RR: 60–650 nmol); dopamine: 1433, 1490, 
1830 nmol (RR: 60–3660 nmol), respectively). Histology 
revealed clusters of well-outlined, clear and granular/
compact cells with no mitotic features, suggestive of 
benign adrenocortical adenoma. This was considered 
sufficient evidence to exclude adrenal metastasis; he was 
accordingly classified as stage 3B melanoma (T4aN1bM0). 
He underwent a left ilioinguinal block dissection 
followed by a ‘watchful wait’ management without 
follow-up imaging.
Thirty months later, an ultrasound scan prompted 
by abdominal discomfort revealed a significant increase 
in the size of the adrenal lesion. This was confirmed by 
cross-sectional imaging showing a 10 cm adrenal lesion 
indenting the inferior liver surface, with likely infiltration 
of the right adrenal vein (Fig.  1A). Clinically, he was 
still hypertensive despite triple therapy with valsartan, 
bendroflumethiazide and amlodipine.
Case 2
A 63-year-old woman presented with unprovoked 
deep vein thrombosis. CT imaging, arranged to 
exclude underlying malignancy, revealed a left adrenal 
tumour (6 cm). Her past medical history included type 
I neurofibromatosis, adrenalectomy for a right-sided 
phaeochromocytoma 20 years earlier and mastectomy for 
breast cancer 13 years earlier.
Investigation
Case 1
After referral to the endocrine team, his plasma 
normetanephrine was confirmed as markedly raised 
(>25 000 pmol/L; normal range (NR): 120–1180 pmol/L), 
with marginally elevated plasma metanephrine 
Figure 1
Imaging and immunohistochemistry characteristics of patient 1, a 
65-year-old gentleman with an adrenal mass detected upon staging for a 
newly diagnosed melanoma. (Panel A) Abdominal CT revealing large, 
heterogeneous right adrenal mass (arrows). (Panel B) Adrenalectomy 
specimen with a melanoma metastasis (arrow) embedded in a sizeable 
phaeochromocytoma. (Panel C) Chromogranin staining showing positive 
phaeochromocytoma cells on the left (brown, arrow) and negative 
melanoma cells on the right. (Panel D) Melan A immunohistochemistry 
showing positive melanoma cells on the right (brown, arrow) and negative 
phaeochromocytoma cells on the left. (Panel E) H&E stain including the 
phaeochromocytoma on the left (arrow) and the melanoma metastasis 
on the right (dashed arrow).
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(641 pmol/L; NR: 80–510 pmol/L); the remainder of the 
endocrine work-up was normal.
Case 2
Biochemistry revealed increased plasma normetanephrine 
(14  409 pmol/L) and metanephrine (112  847 pmol/L), 
diagnostic of a new phaeochromocytoma. MIBG imaging 
confirmed a 7 × 6 × 4 cm left-sided phaeochromocytoma 
and excluded extra-adrenal dissemination.
Treatment
Case 1
He was commenced on alpha-blockade with doxazosin 
and went on to have a right adrenalectomy, more than 
3 years after his initial presentation.
Case 2
She was commenced on alpha and beta-blockade with 
phenoxybenzamine and propranolol and underwent 
laparoscopic left adrenalectomy.
Outcome and follow-up
Case 1
Surprisingly, histology revealed a melanoma metastasis 
(3.2 cm in maximum diameter) embedded in a large 
phaeochromocytoma (14 × 13 × 10 cm) with features 
suggestive of malignant potential (PASS 5/20) (Fig.  1B, 
C, D and E). Genetic testing for phaeochromocytoma 
candidate genes was negative. Four months later 
he developed inguinal lymphadenopathy; cytology 
obtained from aspiration revealed metastatic melanoma. 
Within 8  months of surgery he developed widespread 
metastatic disease, which failed to respond to 
chemotherapy with dacarbazine. He passed away 
12 months after his adrenalectomy.
Case 2
Histology revealed a phaeochromocytoma infiltrated 
by a poorly differentiated carcinoma (Fig.  2). The 
chromaffin tissue had several histological parameters 
consistent with malignant potential, including necrotic 
areas, hypercellularity, spindle cell foci, high mitotic 
rate (9 per 10 high-powered fields), capsular infiltration 
and extension into the surrounding adipose tissue 
(PASS 14/20). Microscopy of the infiltrating carcinoma 
indicated breast origin (lobular adenocarcinoma), in 
keeping with the patient’s history of lobular carcinoma 
of the breast. It comprised sheets of medium-sized cells 
with increased nuclear-to-cytoplasmic ratio that stained 
positive for markers CK, AE1/3, CK7 and ER, consistent 
with a diagnosis of metastatic breast carcinoma. Post-
operatively, she was started on anastrazole and remained 
disease-free on follow-up 1 year post-operatively, at which 
point she was discharged back to her local hospital. She 
eventually developed inoperable recurrence of her breast 
cancer and passed away three and a half years after her 
adrenalectomy.
Discussion
In this report we describe two rare cases of composite 
adrenal tumours, each consisting of a phaeochromocytoma 
with malignant features and a metastatic tumour 
originating from another, extra-adrenal primary 
malignancy. Phaeochromocytomas often develop in the 
Figure 2
Immunohistochemistrycharacteristicsofthetumourremovedfrompatient2,a63-year-oldladywithneurofibromatosistype1andpreviousbreast
cancer, now presenting with a newly diagnosed adrenal mass and increased plasma metanephrine and normetanephrine indicative of 
phaeochromocytoma.(PanelAandB)Showthesamesectionwithtwodifferentstainings.(PanelA)Sectionofthetumourshowingchromogranin-
positive, brown phaeochromocytoma cells (arrow) mixed with the negative metastatic breast adenocarcinoma cells. (Panel B) Section of the tumour, in 
contrast to panel A, showing the oestrogen receptor-positive, brown-stained breast carcinoma cells (arrow) and negative phaeochromocytoma cells. 
PanelC,H&Esectionofthetumour,lowpower(inset)andhighpower,showingsmall,darkbreastcarcinomacellsinfiltratingbetweenthepale
phaeochromocytoma cells.
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context of hereditary, genetic syndromes such as multiple 
endocrine neoplasia type 2, succinate dehydrogenase 
subunit mutations, Von Hippel–Lindau syndrome and 
Neurofibromatosis type 1 (3). The latter is also associated 
with an increased risk of breast cancer, accounting for 
the concurrence of these two tumours in our second 
patient (4, 5). To our knowledge, only four cases of 
adrenal lesions consisting of a phaeochromocytoma 
and a secondary deriving from a non-chromaffin, extra-
adrenal primary malignancy have been previously 
described in the literature (6, 7, 8, 9). The metastatic 
neoplasms in these cases comprised a squamous cell 
carcinoma of the lung (6), a medullary cell carcinoma 
of the thyroid (in a patient with multiple endocrine 
neoplasia type 2A) (7) and ipsilateral renal cell carcinomas 
in the remaining two cases (8, 9). In our patient with the 
phaeochromocytoma containing a melanoma metastasis, 
the metastatic malignant cells formed a discrete lesion 
embedded within the larger chromaffin mass, similar 
to the previously reported cases. By contrast, in the 
phaeochromocytoma/breast cancer case the two groups 
of malignant cells were diffusely intertwined within the 
adrenal mass. To our knowledge, no adrenal lesions with 
this feature have been previously reported. Given the high 
vascularity of chromaffin tumours, it is plausible that 
phaeochromocytomas may act like sieves, extracting and 
retaining circulating tumour cells originating from extra-
adrenal primary sites. We speculate that the malignant 
nature of the phaeochromocytoma in our two cases may 
be associated with more irregular vascularization, making 
it more likely for circulating tumour-cells to be retained.
Our first case also emphasises the importance of 
methodical work-up in all patients with adrenal tumours. 
The double challenge facing the attending clinician is to 
exclude hormone excess and the possibility of malignancy, 
as malignant tumours (primary or metastatic) comprise 
a substantial minority of adrenal incidentalomas (1). All 
currently employed imaging modalities have sub-optimal 
performance at excluding adrenal malignancy (2), and a 
low threshold for surgical intervention should be applied 
in cases with suspicious features (maximum diameter 
>4 cm, high tumour density on CT, no loss of signal 
on out-of-phase MRI). Importantly, adrenal biopsy has 
several limitations, most notably sub-optimal diagnostic 
accuracy (10). In our case, percutaneous biopsy was 
misleading, missing both underlying malignant tumours 
and leading to an ill-advisedly complacent management 
approach. Given that the adrenal mass was of considerable 
size and the only remaining lesion potentially associated 
with the melanoma, it would have been appropriate 
to proceed with surgical removal of the adrenal mass 
after biochemical exclusion of phaeochromocytoma. 
Theoretically, given the past history of lymphoma, albeit 
30 years ago, a percutaneous biopsy could have preceded 
this, with a clear plan to proceed to adrenalectomy should 
histopathology not reveal lymphoma.
In conclusion, the differential diagnosis of an adrenal 
incidentaloma includes life-threatening pathologies 
that call for careful evaluation and low threshold for 
surgical intervention where the risk of malignancy is high 
(1). Percutaneous adrenal biopsies are rarely indicated 
and can be misleading (1, 10). Phaeochromocytomas 
harbouring metastatic deposits from non-chromaffin, 
extra-adrenal primaries represent an exceedingly rare but 
highly intriguing entity, likely attributable to the high 
vascularity of adrenal medullary tumours, which allows 
them to filter out malignant cells of extra-adrenal origin 
from the bloodstream.
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